Peroperative Assessment of Malignancies of the Head and Neck Using High-resolution 18F-FDG-PET/CT

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

August 28, 2020

Primary Completion Date

September 30, 2022

Study Completion Date

September 30, 2022

Conditions
Head and Neck NeoplasmsThyroid NeoplasmSkin Neoplasm
Interventions
DIAGNOSTIC_TEST

high-resolution PET-CT specimen imaging.

"Included patients are given a single weight-dependent activity of 18F-FDG at the department of Nuclear Medicine. After administration, patients are brought to the operating room where standard of care surgical removal of the malignancy is performed.~The resected specimen(s) are brought to the imaging lab and scanned using a preclinical and/or a dedicated specimen PET/CT device. Following PET/CT imaging, the specimen is brought to the department of pathology, where it is sliced. Some of these slices are then rescanned using the preclinical PET/CT device. Moreover, frozen sections are made from one of these slices with macroscopically visible malignant tissue and placed on an autoradiograph overnight. Finally, the imaging results are then correlated to the results found during histopathological analysis of the specimens."

Trial Locations (1)

B-9000

Ghent University Hospital, Ghent

All Listed Sponsors
collaborator

XEOS Medical

INDUSTRY

lead

University Hospital, Ghent

OTHER

NCT05068687 - Peroperative Assessment of Malignancies of the Head and Neck Using High-resolution 18F-FDG-PET/CT | Biotech Hunter | Biotech Hunter